Case Western Reserve University School of Medicine is one of six recipients of a five-year, $10.8 million award from the National Institute on Aging, part of the National Institutes of Health, to establish the Coordinating Center for Genetics and Genomics of Alzheimer's disease.
A five-year, projected $10.8 million award from the National Institute on Aging will establish the Coordinating Center for Genetics and Genomics of Alzheimer's Disease, a joint venture of researchers from the Perelman School of Medicine at the University of Pennsylvania and five other institutions.
ROCHESTER, Minn. — On May 26, the National Institutes of Health (NIH) awarded Mayo Clinic $142 million over five years to serve as home for the 1-million-person Precision Medicine Initiative® (PMI) biobank. Precision Medicine Defined: Precision, or personalized medicine, is a model of care that customizes medical treatment to each individual. To illuminate differences and […]
By RONALD WYATT, MD Civility is a system value that improves safety in health care settings. The link between civility, workplace safety and patient care is not a new concept. The 2004 Institute of Medicine report, “Keeping Patients Safe: Transforming the Work Environment of Nurses,” emphasizes the importance of the work environment in which nurses
Nutritional supplements are big business. It’s estimated that 64% of people use medicinal plants for therapeutic purposes. According to the National Institutes of Health, U.S. sales of dietary supplements reached $36.7 billion in 2014. The herbal medicine market is worth $60 billion globally and growing fast. Show More Summary
Pharmaceutical companies and other sponsors of clinical drug trials are required to report results to ClinicalTrials.gov, a registry run by the U.S. National Library of Medicine (NLM) at the National Institutes of Health (NIH). It's the largest clinical trials database, currently holding registrations from about 200,000 trials. read more
LA JOLLA, CA--June 15, 2016--Scientists at The Scripps Research Institute (TSRI) have developed a powerful new method for finding drug candidates that bind to specific proteins. read more
What won Alexis Borisy over was the idea of software bugs. Borisy, now a partner at Third Rock Ventures, along with four scientists affiliated with MIT and Harvard's Broad Institute who were leaders in cancer genomics got started back in 2008 working on what would soon become Foundation Medicine (No. Show More Summary
Scientists at The Scripps Research Institute have developed a powerful new method for finding drug candidates that bind to specific proteins, an advance that can be applied to a large set of proteins at once, even to the thousands of distinct proteins directly in their native cellular environment.
HOUSTON - (June 13, 2016) - Notch signaling is involved in prostate cancer and, in a paper published today in The Journal of Clinical Investigation, researchers from Baylor College of Medicine and other institutions have shown that, in a mouse model of the disease, Notch promotes metastasis, or the ability of the tumors to spread to other organs. read more
This week, scientists at the Ottawa Hospital Research Institute announced that they have finally discovered a cure for MS. Dr. Harold Atkins is Medical Director of the Regenerative Medicine Program at the Ottawa Hospital Research Institute, and he is convinced that a treatment called IAHSCT can now be used to treat people whose lives have... Show More Summary
The University of California San Diego School of Medicine has launched the Institute for Diabetes and Metabolic Health (IDMH), a new cross-disciplinary, collaborative effort to address one of the nation's leading public health threa...
PHILADELPHIA - Evidence of DNA "scrunching" may one day lead to a new class of drugs against viruses, according to a research team from the Perelman School of Medicine at the University of Pennsylvania, the Georgia Institute of Technology, and Columbia University. Show More Summary
PLOS Medicine’s Senior Research Editor Clare Garvey interviews Elaine Mardis and Marc Ladanyi, Guest Editors for our Special Issue on the Actionable Cancer Genome Elaine Mardis is co-Director of the McDonnell Genome Institute and Robert E. and
Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with recurrent glioblastoma.
Karen Ring, of the California Institute for Regenerative Medicine, gives an update from the HD CARE symposium at UC Irvine. “Over the next five to ten years, we want to make Huntington’s disease an increasingly
An international team led by researchers at the Austrian Institute of Molecular Biotechnology (IMBA) in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. Show More Summary
I recently attended the Institute for Functional Medicine's annual conference. Dr. Jeffrey Bland gave a fascinating overview of the most recent research on clock genes. These are a variety of genes in our bodies (and in most living things) that regulate life functions. Show More Summary
The National Institutes of Health (NIH) has awarded Mayo Clinic $142 million over five years as part of President Obama’s Precision Medicine Initiative to create the world’s largest biobank for the PMI Cohort Program. Mayo Clinic will...Show More Summary
ROCHESTER, Minn. — Mayo Clinic will be awarded $142 million in funding over five years by the National Institutes of Health (NIH) to serve as the national Precision Medicine Initiative (PMI) Cohort Program biobank. The biobank will hold a research repository of biologic samples, known as biospecimens, for this longitudinal program that aims to enroll 1 […]